Introduction
Return of spontaneous circulation (ROSC) following cardiac arrest initiates a complex, systemic pathophysiological state known as post-cardiac arrest syndrome (PCAS). Characterized by post-resuscitation brain injury, myocardial dysfunction, systemic ischemia-reperfusion injury, and the persistent precipitating pathology that caused the arrest, PCAS creates a uniquely hostile physiological environment. Among the interventions available to the resuscitating team, mechanical ventilation plays a pivotal and often underappreciated role in shaping neurological and hemodynamic outcomes. Both hypoxemia and hyperoxemia, as well as hypocapnia and hypercapnia, are independently associated with worsened outcomes following ROSC. Precision ventilator management, targeting narrow physiological windows for oxygen and carbon dioxide, is now a core component of post-resuscitation care bundles endorsed by major resuscitation guidelines. This paper reviews the current science underpinning ventilator strategies in the post-cardiac arrest period, encompassing oxygenation targets, ventilation goals, lung-protective strategies, and evolving evidence on titrated versus liberal oxygen approaches.
Post-Cardiac Arrest Syndrome and the Rationale for Precise Ventilation
The brain is the organ most vulnerable to the ischemic insult of cardiac arrest and the subsequent reperfusion injury following ROSC. Cerebral autoregulation, the brain's capacity to maintain constant perfusion across a range of systemic pressures, is impaired or abolished in many post-arrest patients, rendering cerebral blood flow (CBF) directly pressure- and gas-dependent. Both arterial carbon dioxide tension (PaCO₂) and arterial oxygen tension (PaO₂) exert powerful effects on CBF: hypocapnia causes cerebral vasoconstriction and ischemia, while hypercapnia produces vasodilation and may worsen cerebral oedema. Hyperoxemia generates reactive oxygen species that exacerbate reperfusion injury at the mitochondrial level (Kilgannon et al., 2010). These physiological realities demand that ventilation in the post-arrest period be deliberately and precisely titrated, rather than managed empirically.
Oxygenation Targets: Avoiding Hyperoxemia and Hypoxemia
The dangers of both extremes of oxygenation following cardiac arrest have been established across multiple observational and interventional studies. Kilgannon et al. (2010), in a landmark analysis of over 6,000 ICU admissions following cardiac arrest, demonstrated that exposure to supranormal arterial oxygen tensions (PaO₂ > 300 mmHg) was independently associated with higher in-hospital mortality compared to normoxaemia or hypoxemia. Conversely, hypoxemia following ROSC is equally harmful, exacerbating the post-arrest cerebral injury already underway.
Current American Heart Association (AHA) and European Resuscitation Council (ERC) guidelines recommend titrating inspired oxygen to achieve an SpO₂ of 94–98% (or PaO₂ of approximately 75–100 mmHg) once reliable pulse oximetry is established after ROSC (Nolan et al., 2021; Panchal et al., 2019). The practice of providing 100% FiO₂ as a default following resuscitation, once standard, is now explicitly discouraged in patients with measurable oxygen saturation. The ICU-ROX trial (Young et al., 2019) found no significant benefit to conservative versus liberal oxygen strategies across a broad ICU population, though post-hoc analyses suggested potential harm from hyperoxemia in the cardiac arrest subgroup, reinforcing the guideline-driven approach.
Carbon Dioxide Targets: The Ventilation Controversy
Arterial carbon dioxide management in post-arrest ventilation has attracted increasing scientific scrutiny. Hypocapnia, commonly produced by over-ventilation during or after resuscitation, causes cerebral vasoconstriction, reduces CBF, and may worsen neurological injury. Hypercapnia, conversely, dilates cerebral vasculature but risks increasing intracranial pressure and exacerbating cerebral oedema, particularly in patients with significant post-arrest brain injury. For these reasons, guidelines have traditionally recommended targeting normocapnia (PaCO₂ 35–45 mmHg) in the post-arrest period (Nolan et al., 2021).
However, emerging evidence challenges strict normocapnia as the universal target. The TAME Cardiac Arrest Trial (Eastwood et al., 2023), a multicenter, randomized controlled trial, compared mild therapeutic hypercapnia (PaCO₂ 50–55 mmHg) to normocapnia in comatose survivors of out-of-hospital cardiac arrest. While the trial found no statistically significant improvement in the primary neurological outcome, it demonstrated safety of mild hypercapnia and suggested possible benefit in specific subgroups. This work has reopened scientific debate about individualized CO₂ targets, and further trials are anticipated. At present, guidelines continue to recommend normocapnia as the standard target, while acknowledging the evolving evidence landscape.
Lung-Protective Ventilation in the Post-Arrest Patient
Post-cardiac arrest patients frequently develop pulmonary complications, including aspiration pneumonitis, neurogenic pulmonary oedema, and acute respiratory distress syndrome (ARDS) — all of which may develop in the hours to days following ROSC. Application of lung-protective ventilation (LPV) principles, specifically low tidal volumes of 6–8 mL/kg ideal body weight (IBW) and plateau pressures maintained below 30 cmH₂O, is therefore appropriate and widely recommended in this population, mirroring the evidence base established in ARDS management (Geri et al., 2018).
Positive end-expiratory pressure (PEEP) should be titrated to maintain adequate oxygenation while avoiding hemodynamic compromise, particularly relevant given the post-arrest myocardial dysfunction present in many patients. A PEEP of 5–8 cmH₂O is a reasonable starting point, with upward titration guided by oxygenation response and hemodynamic tolerance. Routine use of high PEEP in the absence of documented lung derecruitment is not supported by current evidence in this population. Respiratory rate should be set to achieve the target PaCO₂ range, typically 12–16 breaths per minute, with adjustments guided by serial arterial blood gas analysis or end-tidal CO₂ monitoring.
Role of Capnography and Monitoring
Waveform capnography and continuous SpO₂ monitoring are essential adjuncts to ventilator management in the post-arrest period. End-tidal CO₂ (EtCO₂) correlates imperfectly with PaCO₂ in post-arrest patients, particularly in the setting of hemodynamic instability, pulmonary oedema, or significant dead space ventilation, and arterial blood gas analysis remains the gold standard for guiding CO₂ and oxygenation targets (Kodali & Urman, 2014). Monitoring trends in EtCO₂ in concert with serial ABGs allows clinicians to maintain target ranges reliably. Continuous monitoring of plateau pressure, driving pressure, and dynamic compliance provides early detection of evolving pulmonary pathology. In centers with advanced neuromonitoring capability, continuous electroencephalography (cEEG) and near-infrared spectroscopy (NIRS) may further guide ventilator adjustments based on cerebral perfusion and seizure activity.
Integration with Targeted Temperature Management
Ventilator management in the post-arrest patient cannot be considered in isolation from targeted temperature management (TTM). Cooling to 32–37.5°C, the current standard following the TTM2 trial (Dankiewicz et al., 2021), which demonstrated equivalent outcomes between 33°C and normothermia with active fever prevention, alters respiratory mechanics, CO₂ production, and oxygen consumption. Hypothermia reduces metabolic rate and CO₂ production, meaning ventilator settings appropriate at normothermia may produce hypocapnia during cooling. Conversely, the rewarming phase increases CO₂ production and may require upward adjustment of minute ventilation. Temperature correction of arterial blood gas values (alpha-stat vs. pH-stat management) should be standardized within institutional protocols to ensure consistent interpretation during TTM. The 2025 AHA recommendations suggest maintaining a temperature between 32°C and 37.5°C after resuscitation, and early death prior to the opportunity for comprehensive prognostication may reflect guideline discordant care (Hirsch, 2025).
Conclusion
Mechanical ventilation in the post-cardiac arrest period is far from a passive intervention. Precise titration of oxygenation and carbon dioxide, application of lung-protective tidal volumes, appropriate PEEP selection, and integration with TTM collectively define a ventilator strategy aimed at mitigating the secondary neurological and systemic injury that characterizes PCAS. The evidence base continues to evolve, particularly around CO₂ targets, but the foundational principles of avoiding hyperoxemia, preventing hypocapnia, and protecting the lung remain firmly established. For paramedics and advanced practice clinicians managing post-arrest patients in both prehospital and hospital environments, proficiency in these ventilator strategies is an essential component of high-quality resuscitation science.
References
- Dankiewicz, J., Cronberg, T., Lilja, G., Jakobsen, J. C., Levin, H., Ullen, S., ... & Nielsen, N. (2021). Hypothermia versus normothermia after out-of-hospital cardiac arrest. New England Journal of Medicine, 384(24), 2283–2294.
https://doi.org/10.1056/NEJMoa2100591
- Eastwood, G. M., Nichol, A., Hodgson, C. L., Parke, R. L., McGuinness, S., Nielsen, N., ... & Bellomo, R. (2023). Mild hypercapnia or normocapnia after out-of-hospital cardiac arrest (TAME): A multicentre, open-label, randomised, controlled trial. The Lancet, 401(10389), 1693–1703.
https://doi.org/10.1016/S0140-6736(23)00806-9
- Geri, G., Vignon, P., Aubry, A., Fedou, A. L., Charron, C., Silva, S., ... & Vieillard-Baron, A. (2018). Cardiovascular clusters in post-cardiac arrest shock are associated with different outcomes and responses to treatment. Intensive Care Medicine, 44(11), 1846–1855.
https://doi.org/10.1007/s00134-018-5329-4
- Hirsch, Karen, Amorim, Coppler, Et al; Part 11: Post–Cardiac Arrest Care: 2025 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Circulation, Volume 152, Number 16_suppl_2,
https://doi.org/10.1161/CIR.0000000000001375
- Kilgannon, J. H., Jones, A. E., Shapiro, N. I., Angelos, M. G., Milcarek, B., Hunter, K., ... & Trzeciak, S. (2010). Association between arterial hyperoxia following resuscitation from cardiac arrest and in-hospital mortality. JAMA, 303(21), 2165–2171.
https://doi.org/10.1001/jama.2010.707
- Kodali, B. S., & Urman, R. D. (2014). Capnography during cardiopulmonary resuscitation: Current evidence and future directions. Journal of Emergencies, Trauma, and Shock, 7(4), 332–340.
https://doi.org/10.4103/0974-2700.142778
- Nolan, J. P., Sandroni, C., Bottiger, B. W., Cariou, A., Cronberg, T., Friberg, H., ... & Soar, J. (2021). European Resuscitation Council and European Society of Intensive Care Medicine guidelines 2021: Post-resuscitation care. Resuscitation, 161, 220–269.
https://doi.org/10.1016/j.resuscitation.2021.02.012
- Wigginton, J.G. ∙ Agarwal, S. ∙ Bartos, J.A. ...Part 9: adult advanced life support: 2025 American Heart Association guidelines for cardiopulmonary resuscitation and emergency cardiovascular care. Circulation. 2025; 152(16_suppl_2):S538-S577
- Young, P., Mackle, D., Bellomo, R., Bailey, M., Beasley, R., Deane, A., ... & Weatherall, M. (2019). Conservative oxygen therapy for mechanically ventilated adults with sepsis: A post hoc analysis of data from the ICU-ROX trial. Intensive Care Medicine, 46(1), 17–26.
https://doi.org/10.1007/s00134-019-05857-x
- Wigginton, J.G. ∙ Agarwal, S. ∙ Bartos, J.A. ...Part 9: adult advanced life support: 2025 American Heart Association guidelines for cardiopulmonary resuscitation and emergency cardiovascular care. Circulation. 2025; 152(16_suppl_2):S538-S577